Go to the page content
Obesity

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Locations

United States

Start date

03/09/2024

Identifiers

Trial ID NN9638-7569,
NCT number NCT06577766,
Eudract number Not Available

Summary

The study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in your body, and what your body does to the study medicine. Participants will either get the study medicine or placebo (a "dummy medicine" similar to the study medicine but without active ingredients) given as an injection under your skin. Which treatment the participants get is decided by chance. The study medicine is a potential new medicine which cannot be prescribed by doctors.

Trial Overview:

Condition

Obesity

Overweight

Treatment

DRUG: NNC0638-0355

DRUG: Placebo (NNC0638-0355)

Study type

INTERVENTIONAL

Trial duration

Sep 03 2024 - Sep 18 2025

Participants

88

Phase

I

Are you eligible?

Gender

Male and female

Age

18 to 55 years old

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.